Radiologists influence cost of incidental MRI follow-up
When radiologists find incidental pancreatic cysts on MRI scans, patients can...Read more on AuntMinnie.comRelated Reading: Contrast US more accurately types pancreatic lesions Incidental imaging findings boost healthcare costs USPSTF seeks comment on pancreatic cancer guidance PET/MRI head scans reveal important incidental findings Primary care doctors want help with incidental findings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 15, 2018 Category: Radiology Source Type: news

Being deficient in magnesium increases your risk of pancreatic cancer by 76%
(Natural News) Pancreatic cancer: It’s a silent killer that now claims the lives of as many as 55,000 people every single year. But a new study suggests that magnesium, a simple, inexpensive trace mineral, may be powerfully effective in helping to stamp it out without the need for chemotherapy or radiation. The latest World Health... (Source: NaturalNews.com)
Source: NaturalNews.com - October 13, 2018 Category: Consumer Health News Source Type: news

Is the next big step in cancer therapy personalized vaccines?
(University of California - San Diego) Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 12, 2018 Category: Biology Source Type: news

OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi(R) in Combination with Nivolumab in Pancreatic Cancer
The Phase 2 clinical trial of Tedopi® in pancreatic cancer will be sponsored by the oncology group GERCOR The study will explore Tedopi®’s potential in an additional oncology indication NANTES, France, Oct. 10, 2018 -- (Healthcare Sales & Mar... Biopharmaceuticals, Oncology, Regulatory OSE Immunotherapeutics, Tedopi, pancreatic cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 10, 2018 Category: Pharmaceuticals Source Type: news

Killer cell immunotherapy offers potential cure for advanced pancreatic cancer
(Queen Mary University of London) A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to early research by Queen Mary University of London. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 10, 2018 Category: Cancer & Oncology Source Type: news

Noncolorectal Gastrointestinal Cancer | Medscape Noncolorectal Gastrointestinal Cancer | Medscape
Noncolorectal gastrointestinal cancers include pancreatic, hepatobiliary, gastric, small bowel, and esophageal cancer. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

Scientists look at anacardic acid as a potential treatment for pancreatic cancer
(Natural News) The fruit and seeds of the cashew tree are known to provide many beneficial nutrients and products. Kentucky-based researchers have recently found another positive property, this time related to cancer. They reported that anacardic acid from cashew nuts could help mitigate the growth and spread of pancreatic cancer. A highly aggressive form of... (Source: NaturalNews.com)
Source: NaturalNews.com - October 9, 2018 Category: Consumer Health News Source Type: news

UAB center dedicated to pancreas and bile duct diseases established
UAB has established a new program to treat diseases of the pancreas and bile ducts. The new Pancreatobiliary Disease Center within the UAB School of Medicine plans to link medical professionals from across UAB Medicine involved in managing pancreatobiliary diseases, which includes pancreatic and gallbladder cancer, cysts, bile duct injuries and bile duct injures. “While malign ancies of the pancreas and bile duct present their own unique challenges to treatment, so do the litany of benign diseases… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 8, 2018 Category: American Health Authors: Tyler Patchen Source Type: news

Genetic mutation may increase risk of pancreatic cancer in females
(Lawson Health Research Institute) In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine& Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females. The study marks the first time a sex-specific genetic risk factor for pancreatic cancer has been identified. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

CAR T-Cell Therapy May ‘ Change the Paradigm of Treating Mesothelioma ’
Thoracic surgeon and scientist Dr. Prasad Adusumilli at Memorial Sloan Kettering (MSK) Cancer Center believes customized gene therapy will soon change the way pleural mesothelioma is treated. Adusumilli, director of the Mesothelioma Program at MSK, has worked for a decade on developing tumor immunology for thoracic malignancies. He is currently the principal investigator of a phase I clinical trial involving specially prepared immune cells — chimeric antigen receptor (CAR) T cells — that have shown impressive efficacy with mesothelioma. “I think this is going to change the paradigm of treating mesotheliom...
Source: Asbestos and Mesothelioma News - October 1, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

What's new on L.A.'s wellness scene
A yoga event benefits families in India, a way to do a virtual 5K, a run/walk raises money for pancreatic cancer research, and high-tech wellness comes to Orange County and Glendale. Here are some ways to feel good - and also do good - as we ease into October. (Source: L.A. Times - Health)
Source: L.A. Times - Health - September 28, 2018 Category: Consumer Health News Authors: Kavita Daswani Source Type: news

What's new on L.A.'s wellness scene
A yoga event benefits families in India, a way to do a virtual 5K, a run/walk raises money for pancreatic cancer research, and high-tech wellness comes to Orange County and Glendale. Here are some ways to feel good — and also do good — as we ease into October.The nonprofit organization Yoga Gives... (Source: L.A. Times - Health)
Source: L.A. Times - Health - September 28, 2018 Category: Consumer Health News Authors: Kavita Daswani Source Type: news

Medical News Today: A new drug could strip pancreatic cancer of its defenses
A common type of pancreatic cancer is aggressive and highly treatment-resistant. Experts have now developed a drug that may kill this cancer more easily. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 27, 2018 Category: Consumer Health News Tags: Pancreatic Cancer Source Type: news

Pancreatic cancer warning - does your urine look like this? How to check for cancer in wee
PANCREATIC cancer symptoms include unexplained weight loss, back pain, and vomiting. But, you could also be at risk of tumour signs if your wee looks like this. (Source: Daily Express - Health)
Source: Daily Express - Health - September 26, 2018 Category: Consumer Health News Source Type: news

New drug supercharges pancreatic cancer treatments and may boost survival rates by 50%
Pancreatic cancer is so deadly because its location makes it difficult to catch early and because it becomes chemo resistant. But a new drug developed by Cedars-Sinai Medical center may change that. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2018 Category: Consumer Health News Source Type: news

Pancreatic cancer: If you have this condition you could be more at risk
PANCREATIC cancer doesn ’t have any specific causes, but there are various risk factors which could increase the chance of developing the disease. Having diabetes is one of them. (Source: Daily Express - Health)
Source: Daily Express - Health - September 25, 2018 Category: Consumer Health News Source Type: news

New drug blocks pancreatic cancer growth in mice, study finds
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai. The study, published recently in the journal Gastroenterology, also demonstrated in mice that the drug, called Metavert, may prevent patients from developing a resistance to currently used pancreatic cancer chemotherapies. (Source: World Pharma News)
Source: World Pharma News - September 25, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Most people with cancer risk genes have no idea
More than 80 percent of people with identifiable genetic risk for breast, ovarian, prostate and pancreatic cancer are unaware of the situation, a study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 24, 2018 Category: Consumer Health News Source Type: news

Pancreatic cancer symptoms: This common problem could indicate the disease
PANCREATIC cancer symptoms are ’t usually present in the early stages of the disease, making it difficult to diagnose. However, symptoms may appear as the disease progresses, such as this common everyday problem. (Source: Daily Express - Health)
Source: Daily Express - Health - September 24, 2018 Category: Consumer Health News Source Type: news

Eight Out Of Ten People With The Same Cancer Risk Gene As Angelina Jolie Don't Know They Have It
Despite frequently engaging with their healthcare providers, 8 out of 10 people with a cancer susceptibility gene don't know they are at risk of breast, ovarian, prostate and pancreatic cancers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 21, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Eight of 10 people with cancer risk genes don't know it
(Yale University) Genomic screening of more than 50,000 people shows that more than 80 percent of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 21, 2018 Category: Cancer & Oncology Source Type: news

Pancreatic cancer symptoms: This type of body temperature could be a sign of the disease
PANCREATIC cancer symptoms don ’t usually appear at the early stages, but they will eventually develop. If you experience this type of body temperature, along with other symptoms, it could indicate the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2018 Category: Consumer Health News Source Type: news

Novel Mesothelioma Treatment Closer to FDA Approval
Standard-of-care treatment for patients with pleural mesothelioma may soon include Tumor Treating Fields (TTF), a novel therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth. In the wake of recently released results from Novocure’s STELLAR phase II clinical trial, the U.S. Food and Drug Administration (FDA) is expected to approve the treatment within the next six months, giving mesothelioma patients another much-needed option. “At this point, it should be a relatively rapid approval process,” Dr. Eilon Kirson, chief science officer at Novocure, the oncology company...
Source: Asbestos and Mesothelioma News - September 17, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Pancreatic cancer symptoms: If your skin turns this colour you could have the disease
PANCREATIC cancer symptoms are not usually evident in the early stages of the disease, but one of the first symptoms you may notice is if your skin turns this colour. (Source: Daily Express - Health)
Source: Daily Express - Health - September 17, 2018 Category: Consumer Health News Source Type: news

New blood test detects early stage pancreatic cancer
(Lund University) Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test developed by researchers at Lund University in Sweden, Herlev Hospital, Knight Cancer Center and Immunovia AB, can detect pancreatic cancer in the very earliest stages of the disease. The results have been published in the Journal of Clinical Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 17, 2018 Category: International Medicine & Public Health Source Type: news

Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
When Nichelle Obar learned she was pregnant with her second child last year, she never expected that her pregnancy, or her baby, would make history. But when the 40-year-old food-and-beverage coordinator from Hawaii and her fiancé Christopher Constantino went to their 18-week ultrasound, they learned something was wrong. The heart was larger than it should have been, and there was evidence that fluid was starting to build up around the organ as well. Both were signs that the fetus was working extra hard to pump blood to its fast-growing body and that its heart was starting to fail. Obar’s doctor knew what coul...
Source: TIME: Science - September 13, 2018 Category: Science Authors: Alice Park Tags: Uncategorized medicine Source Type: news

Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
When Nichelle Obar learned she was pregnant with her second child last year, she never expected that her pregnancy, or her baby, would make history. But when the 40-year-old food-and-beverage coordinator from Hawaii and her fiancé Christopher Constantino went to their 18-week ultrasound, they learned something was wrong. The heart was larger than it should have been, and there was evidence that fluid was starting to build up around the organ as well. Both were signs that the fetus was working extra hard to pump blood to its fast-growing body and that its heart was starting to fail. Obar’s doctor knew what coul...
Source: TIME: Health - September 13, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Innovation Health medicine Source Type: news

Drug for pancreatic cancer developed by college of pharmacy researchers
A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease. Ruiwen Zhang, M.D., Ph.D. and Robert L. Boblitt Endowed Professor in Drug Discovery, has published his findings, along with research associate professor of pharmacology Wei Wang, M.D., Ph.D., in Cancer Research Journal. (Source: World Pharma News)
Source: World Pharma News - September 12, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Drug for pancreatic cancer developed by college of pharmacy researchers
(University of Houston) University of Houston researchers have developed a new medicine that can inhibit two of the major pathways of pancreatic cancer. The new synthetic compound is based on a type of sea sponge. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 11, 2018 Category: Cancer & Oncology Source Type: news

Boston Scientific puts up $600m for Augmenix
Boston Scientific (NYSE:BSX) said yesterday that it put $600 million on the table for Augmenix and its SpaceOar device. The deal for Bedford, Mass.-based Augmenix calls for $500 million in up-front cash and another $100 million pegged to sales-based milestones, Boston said. The SpaceOar hydrogel device, which won CE Mark approval in the European Union in 2010 and 510(k) clearance from the FDA in April 2015 , is designed to separate the prostate from the rectal wall during radiation treatment for prostate cancer. The product is delivered through a small needle as a liquid, which then solidifies into a so...
Source: Mass Device - September 7, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Wall Street Beat Augmenix Inc. Boston Scientific Source Type: news

Minimal functional driver gene heterogeneity among untreated metastases
Metastases are responsible for the majority of cancer-related deaths. Although genomic heterogeneity within primary tumors is associated with relapse, heterogeneity among treatment-naïve metastases has not been comprehensively assessed. We analyzed sequencing data for 76 untreated metastases from 20 patients and inferred cancer phylogenies for breast, colorectal, endometrial, gastric, lung, melanoma, pancreatic, and prostate cancers. We found that within individual patients, a large majority of driver gene mutations are common to all metastases. Further analysis revealed that the driver gene mutations that were not share...
Source: ScienceNOW - September 6, 2018 Category: Science Authors: Reiter, J. G., Makohon-Moore, A. P., Gerold, J. M., Heyde, A., Attiyeh, M. A., Kohutek, Z. A., Tokheim, C. J., Brown, A., DeBlasio, R. M., Niyazov, J., Zucker, A., Karchin, R., Kinzler, K. W., Iacobuzio-Donahue, C. A., Vogelstein, B., Nowak, M. A. Tags: Medicine, Diseases reports Source Type: news

Alpha Tau Medical raises $29m
Alpha Tau Medical said today it raised $29 million in a private funding round to help support its alpha radiation cancer therapy technology. The round was led by Israeli private equity firm Shavit Capital and joined by global equity crowdfunding platform OurCrowd.com and Medison Pharma venture capital arm Medison Ventures, the Israel-based company said. The round was also joined by Apax Partner founds Ronald Cohen and Alan Patricof, Alpha Tau said. “We are confident that Alpha Tau’s ground-breaking technology can be a game changer in the treatment of cancer. Importantly, under the guidance of an exper...
Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Alpha Tau Medical Source Type: news

New nuclear medicine imaging method shows strong potential for cancer imaging
(Society of Nuclear Medicine and Molecular Imaging) A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 5, 2018 Category: International Medicine & Public Health Source Type: news

Microbiome Dysbiosis Promotes Pancreatic Disease (CME/CE)
(MedPage Today) -- Microbiome check may benefit those at risk for pancreatitis and cancer (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 30, 2018 Category: Gastroenterology Source Type: news

Stars Rally Together Again For Stand Up To Cancer ’ s Live Broadcast On September 7
LOS ANGELES– Stand Up To Cancer (SU2C), a division of the Entertainment Industry Foundation (EIF), is proud to announce that the Hollywood community is rallying together yet again to support the sixth biennial televised fundraising special. CBS will donate one hour of commercial-free primetime to broadcast the event on Friday, Sept. 7  from 8:00 – 9:00 PM ET/PT (7:00 – 8:00 PM CT). Mahershala Ali, Kathy Bates, Katie Couric, Jennifer Garner, Tony Hale, Marg Helgenberger, Ed Helms, Ken Jeong, Marlee Matlin, Matthew McConaughey, Maria Menounos, Jillian Michaels, Trevor Noah, Dak Prescott, Italia Ricci, ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 28, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Only CBS Stand Up To Cancer Source Type: news

Pancreatic cancer symptoms: Watch out for these changes in your bowel habit
PANCREATIC cancer symptoms can be vague to begin with as it depends where the cancerous growth is in the pancreas. If signs do show the patient ’s bowel habits may be affected. There are three signs in your stools to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - August 23, 2018 Category: Consumer Health News Source Type: news

GW cancer researchers to develop targeted therapies for pancreatic cancer
(George Washington University) A team at the George Washington University Cancer Center received more than $1.8 million from the National Institutes of Health to develop genetically engineered models to comprehensively study the role of COMPASS, a protein complex that epigenetically regulates cell fate decisions that drive the initiation and progression of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 23, 2018 Category: Cancer & Oncology Source Type: news

Stevie Wonder says Aretha Franklin was killed by global warming... seriously
(Natural News) What killed legendary singer Aretha Franklin earlier this month at age 76? If you’re like most people following her story, you would answer that she died of pancreatic cancer, as widely reported in the media and confirmed by her doctors. If you’re Motown legend Stevie Wonder, however, the answer is quite different. The... (Source: NaturalNews.com)
Source: NaturalNews.com - August 22, 2018 Category: Consumer Health News Source Type: news

Sanford Burnham Prebys compound advances into Phase 1 trial for pancreatic cancer
(Sanford Burnham Prebys Medical Discovery Institute) A compound discovered at Sanford Burnham Prebys Medical Discovery Institute (SBP) has advanced into a Phase 1 trial for metastatic pancreatic cancer. Called CEND-1 (scientifically known as iRGD), the compound was exclusively licensed in 2015 to a private company, DrugCendR Inc. The drug candidate was discovered in the laboratory of Erkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 21, 2018 Category: International Medicine & Public Health Source Type: news

Bioelectric device dev NeoTherma Oncology raises $6m in Series A
Bioelectric device developer NeoTherma Oncology said last week it raised $6 million in a Series A round of financing which is slated to support testing of the company’s devices. Funding was co-led by current investor Gary Barnett and joined by investment groups Flor-Med Partners, R&K Edwards Investments and others, the company said. NeoTherma is developing the VectRx thermal oncology treatment platform designed for treating pancreatic cancer, the Wichita, Kan.-based company said. The device has already won a breakthrough therapy designation from the FDA. “This investment provides us the ability to realize a...
Source: Mass Device - August 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology neothermaoncology Source Type: news

Blood test detects 95% of cancers including hard-to-spot pancreatic forms of the disease
Researchers from the University of Copenhagen found that when 10 cancer cells were exposed to the protein produced by deadly malaria parasites, nine bound to it and could be used for diagnosis. (Source: the Mail online | Health)
Source: the Mail online | Health - August 20, 2018 Category: Consumer Health News Source Type: news

Pancreatic cancer: Why you should never ignore this sign in your poo - Dr Zoe reveals
PANCREATIC cancer symptoms can include weight loss, fatigue and poor digestion. But you could also be at risk of the deadly disease if your stools look like this, revealed ITV This Morning's Dr Zoe Williams. What does a healthy poo look like? (Source: Daily Express - Health)
Source: Daily Express - Health - August 17, 2018 Category: Consumer Health News Source Type: news

Why few survive the pancreatic cancer that killed Aretha Franklin
At 76, Aretha Franklin died of pancreatic cancer, one of the most deadly forms of the disease. An expert explained to Daily Mail Online why, even with the safer form she had, pancreatic cancer kills. (Source: the Mail online | Health)
Source: the Mail online | Health - August 16, 2018 Category: Consumer Health News Source Type: news

The Agonizingly Slow Progress Against The Cancer That Killed Aretha Franklin
Our slow progress against pancreatic cancer is representative of the war on cancer writ large. Focus in on pancreatic cancer, and you see that there has been progress for patients with some subtypes for the disease. There are real reasons for hope that things could improve dramatically. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 16, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:NVS NASDAQ:CELG NYSE:LLY Source Type: news

Why pancreatic cancer is so deadly
Pancreatic cancer is the third-leading cause of death from cancer in the United States, after lung and colorectal cancers (Source: CNN.com - Health)
Source: CNN.com - Health - August 16, 2018 Category: Consumer Health News Source Type: news

Aretha Franklin dead: Queen of Soul dies aged 76 after cancer battle
Aretha Franklin, the long-reigning Queen of Soul, died on Thursday morning at age 76.   Her publicist said she died at her home in Detroit. The cause was advanced pancreatic cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - August 16, 2018 Category: Consumer Health News Source Type: news

Aretha Franklin Dies of Pancreatic Cancer
Aretha Franklin, the "Queen of Soul," died of pancreatic cancer. She had several recent health scares but did not reveal their causes. (Source: WebMD Health)
Source: WebMD Health - August 16, 2018 Category: Consumer Health News Source Type: news

Novocure inks collaboration for pivotal pancreatic cancer trial
Novocure (NSDQ:NVCR) and US Oncology Research said today that the groups are collaborating on a phase III pivotal trial designed to test Novocure’s Tumor Treating Fields with nab-paclitaxel and gemcitabine in patients with unresectable locally advanced pancreatic cancer. Using a network of community-based oncology practices, US Oncology Research plans to open 10 clinical trial sites to enroll patients in Novocure’s Panova-3 trial, the companies reported. Get the full story at our sister site, Drug Delivery Business News. The post Novocure inks collaboration for pivotal pancreatic cancer trial appeared firs...
Source: Mass Device - August 15, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat NovoCure Source Type: news

Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
ST. HELIER, JERSEY, U.K. and THE WOODLANDS, TEXAS, U.S. (August 15, 2018) – Novocure (NASDAQ: NVCR) and US Oncology Research are collaborating on PANOVA-3, a phase 3 pivotal trial testing the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in patients with unresectabl... (Source: McKesson News)
Source: McKesson News - August 15, 2018 Category: Information Technology Source Type: news